Segulah Medical Acceleration

Segulah Medical Acceleration (SMA) seeks to invest in and develop game changing businesses within medical technologies and related value chain solutions. These companies use cutting edge research in real-world applications such as medical devices, diagnostics and life science tools. SMA bridge the gap between innovation and commercial validation to bring advanced research to global markets

Founded 2020
Investment year 2021
Invested through AB Segulah
CEO Gabriel Urwitz
Chairman Claes Ekström
Head Office Stockholm, Sweden
Formal Representation Gabriel Urwitz (CEO, and Board) Mikael Kamras (Board)